Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies
Camilla Evangelisti(University of Bologna), Alberto M. Martelli(University of Bologna)
Cited by 42
Related Papers
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
|Oncotarget|2012|315
Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response.
|Oncotarget|2012|303
Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
|Leukemia|2013|249